Endoscopy 2018; 50(11): 1053-1058
DOI: 10.1055/a-0596-7199
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a multicenter international experience

Michel Kahaleh
1   Rutgers Robert Wood Johnson, New Brunswick, New Jersey, USA
,
Jean-Michel Gonzalez
2   Aarhus University, Marseille, France
,
Ming-ming Xu
3   Gastroenterology, Southern California Permanente Medical Group, Los Angeles, California, USA
,
Iman Andalib
4   Weill Cornell Medical Center, New York, New York, United States
,
Monica Gaidhane
1   Rutgers Robert Wood Johnson, New Brunswick, New Jersey, USA
,
Amy Tyberg
1   Rutgers Robert Wood Johnson, New Brunswick, New Jersey, USA
,
Monica Saumoy
4   Weill Cornell Medical Center, New York, New York, United States
,
Alberto Jose Baptista Marchena
5   Hospital de Clínicas Caracas, San Bernardino, Venezuela
,
Marc Barthet
2   Aarhus University, Marseille, France
› Author Affiliations
Further Information

Publication History

submitted 19 June 2017

accepted after revision 23 February 2018

Publication Date:
12 April 2018 (online)

Abstract

Background Gastroparesis is a difficult-to-treat motility disorder with a poor response to medical therapy. Gastric peroral endoscopic pyloromyotomy (G-POEM) has been offered as a novel therapy in the treatment of refractory gastroparesis. We present a multicenter case series of our experience with G-POEM.

Methods This is an international multicenter case series of patients who underwent G-POEM for the treatment of gastroparesis. The severity of gastroparesis was assessed by delayed gastric emptying scintigraphy (GES) and an elevated gastroparesis cardinal symptoms index (GCSI). Patients then underwent G-POEM using the submucosal tunneling technique. The primary endpoint was improvement in the GCSI score and improvement in gastric emptying on repeat scintigraphy. Secondary endpoints were technical success, complication rate, procedure duration, and length of hospital stay post-procedure.

Results G-POEM was technically successful in all 33 patients. Symptomatic improvement was seen in 28/33 patients (85 %), with a decrease in symptom score by GCSI from 3.3 to 0.8 at follow-up (P < 0.001). The mean procedure duration was 77.6 minutes (37 – 255 minutes). Mean GES improved significantly from 222.4 minutes to 143.16 minutes (P < 0.001). Complications were minimal and included bleeding (n = 1) and an ulcer (n = 1) treated conservatively. The mean length of hospital stay post-procedure was 5.4 days (1 – 14 days). The mean follow-up duration was 11.5 months (2 – 31 months).

Conclusion G-POEM is a technically feasible, safe, and successful procedure for the treatment of refractory gastroparesis. A further multicenter comparative study should be performed to compare this technique to laparoscopic pyloromyotomy.

 
  • References

  • 1 Khashab MA, Ngamruengphong S, Carr-Locke D. et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc 2017; 85: 123-128
  • 2 Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995–2004. Am J Gastroenterol 2008; 103: 313-322
  • 3 Gonzalez JM, Lestelle V, Benezech A. et al. Gastric per-oral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video). Gastrointest Endosc 2017; 85: 132-139
  • 4 Parkman HP. Idiopathic gastroparesis. Gastroenterol Clin North Am 2015; 44: 59-68
  • 5 Sigurdsson L, Flores A, Putnam PE. et al. Postviral gastroparesis: presentation, treatment, and outcome. J Pediatr 1997; 131: 751-754
  • 6 Khashab MA, Stein E, Clarke JO. et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 2013; 78: 764-768
  • 7 Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther 2010; 31: 11-19
  • 8 Hibbard ML, Dunst CM, Swanstrom LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg 2011; 15: 1513-1519
  • 9 OʼGrady G, Egbuji JU, Du P. et al. High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis. World J Surg 2009; 33: 1693-1701
  • 10 Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90: 1919-1925
  • 11 Bromer MQ, Friedenberg F, Miller LS. et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 833-839
  • 12 Friedenberg FK, Palit A, Parkman HP. et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103: 416-423
  • 13 Clarke JO, Sharaiha RZ, Kord Valeshabad A. et al. Through-the-scope transpyloric stent placement improves symptoms and gastric emptying in patients with gastroparesis. Endoscopy 2013; 45 (Suppl. 02) E189-E190
  • 14 Khashab MA, Besharati S, Ngamruengphong S. et al. Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video). Gastrointest Endosc 2015; 82: 1106-1109
  • 15 Gonzalez JM, Benezech A, Vitton V. et al. G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 2017; 46: 364-370
  • 16 Revicki DA, Rentz AM, Dubois D. et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004; 13: 833-844
  • 17 Abell TL, Camilleri M, Donohoe K. et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103: 753-763
  • 18 Tougas G, Eaker EY, Abell TL. et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456-1462
  • 19 Chaves DM, Gusmon CC, Mestieri LH. et al. A new technique for performing endoscopic pyloromyotomy by gastric submucosal tunnel dissection. Surg Laparosc Endosc Percutan Tech 2014; 24: e92-e94
  • 20 Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 5-12 ; quiz e7
  • 21 Coleski R, Anderson MA, Hasler WL. Factors associated with symptom response to pyloric injection of botulinum toxin in a large series of gastroparesis patients. Dig Dis Sci 2009; 54: 2634-2642
  • 22 Camilleri M, Parkman HP, Shafi MA. et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108: 18-37 ; quiz 38
  • 23 Kawai M, Peretta S, Burckhardt O. et al. Endoscopic pyloromyotomy: a new concept of minimally invasive surgery for pyloric stenosis. Endoscopy 2012; 44: 169-173
  • 24 Shlomovitz E, Pescarus R, Cassera MA. et al. Early human experience with per-oral endoscopic pyloromyotomy (POP). Surg Endosc 2015; 29: 543-551
  • 25 Dacha S, Mekaroonkamol P, Li L. et al. Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy (with video). Gastrointest Endosc 2017; 86: 282-289
  • 26 Xue HB, Fan HZ, Meng XM. et al. Fluoroscopy-guided gastric peroral endoscopic pyloromyotomy (G-POEM): a more reliable and efficient method for treatment of refractory gastroparesis. Surg Endosc 2017; 31: 4617-4624